Resources

ANVISA has updated its import authorization procedures for medicines and substances subject to special control. It is worth remembering that…

Argentina ANMAT guide outlines the requirements for decentralized elements in clinical pharmacology studies, including roles and responsibil…

Malaysia has released its first Decentralised Clinical Trial guidance document, which provides detailed guidance on implementing decentralis…

Korea Ministry of Food and Drug Safety (MFDS) proposed a partial revision to Regulations on the Safety of Pharmaceuticals through Safety Not…

According to FDA, this draft guidance describes the FDA’s interpretation of, and policies concerning, the prohibition on wholesaling i…

The Thailand Ministry of Public Health proposes draft standards regarding the Supervision of Herbal Products containing cannabis/hemp flower…

The Thailand Ministry of Public Health published the benefits of promoting, supporting, and developing effective drug research studies, incl…

The TGA has introduced changes regarding the evaluation of new ingredients to be used in Listed (AUST L) and Listed Assessed (AUST L (A)) me…

Real-world evidence is the latest international clinical application trend, which can be used to improve the design of clinical trials, and…

The Thai Food and Drug Administration (TFDA) Issued Criteria, methods, and conditions for the sampling of herbal products manufactured or im…